Table 3.

Comparison of the clinical, laboratory, and functional parameters prior to and after OCS.

N=16	Prior to OCS	Under OCS prior to Mepolizumab	P
Number of asthma exacerbationsin the last 24 weeks, mean ± SD	9.6 ± 8.7	2 ± 2.6	0.001
ACT, mean ± SD	11.9 ± 3.7	18.2 ± 5.5	<0.001
Blood eos %, mean ± SD	13.3 ± 8.9	5.3 ± 5.7	<0.001
Blood eos count mean ± SD	1371 ± 1182	561 ± 591	0.002
FEV1 %, mean ± SD	71.4 ± 19	81 ± 30	0.241
FEV1 L/s, mean ± SD	1920 ± 805	2091 ± 962	0.425

ACT: Asthma control test, eos: eosinophil, OCS: oral corticosteroid